Drug Updates

Anatara’s IBS-D clinical trial to leverage Microba Life Sciences’ precision microbiome analysis

Precision microbiome science company, Microba Life Sciences, will work with Anatara Life Sciences (ASX:ANR) to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D. Anatara have commenced recruitment for a phase 1/2 clinical trial of their Gastrointestinal Re-Programming complementary medicine (GaRP) to address an unmet clinical need for IBS-D.   Microba will apply […]

Device Digest

OptraSCAN Announces CytoSiA – A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN’s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and cytotechnologists in screening and detection of cervical cancer, […]